Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.22 is 17% below its 5-year average of 13.50, near the low end of its 5-year range (3.72–40.74).
As of the fiscal period ended Tuesday, June 30, 2026. 20.74% below its 12-month average of 14.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.22.
QUICK RATIO (ACID-TEST)
11.22
QUICK RATIO (ACID-TEST) AVG TTM
14.15
QUICK RATIO (ACID-TEST) AVG 3Y
16.70
QUICK RATIO (ACID-TEST) AVG 5Y
13.50
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.74%
CURRENT VS 3Y AVG
-32.82%
CURRENT VS 5Y AVG
-16.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 497 covered companies
CURRENT VS SECTOR MEDIAN
+275.11%
vs the sector median at left
Compass Therapeutics, Inc.
Market Cap
$172.99M
Quick Ratio (Acid-Test)
11.22
TTM Avg
14.15
3Y Avg
16.70
5Y Avg
13.50
Market Cap
$173.04M
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.19
3Y Avg
1.52
5Y Avg
2.42
Market Cap
$174.17M
Quick Ratio (Acid-Test)
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$176.96M
Quick Ratio (Acid-Test)
1.25
TTM Avg
2.29
3Y Avg
3.57
5Y Avg
4.16
Market Cap
$179.70M
Quick Ratio (Acid-Test)
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
Market Cap
$162.82M
Quick Ratio (Acid-Test)
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$184.12M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.25
3Y Avg
1.14
5Y Avg
1.20
Market Cap
$153.84M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $172.99M | 11.22 | 14.15 | 16.70 | 13.50 |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | 1.70 | 1.19 | 1.52 | 2.42 |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | 12.82 | 9.83 | 6.43 | 5.45 |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | 1.25 | 2.29 | 3.57 | 4.16 |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | 15.70 | 3.42 | 4.67 | 3.16 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | 9.71 | 4.67 | 6.04 | 19.74 |
| Journey Medical Corporation (DERM)vs › | $184.12M | 1.41 | 1.25 | 1.14 | 1.20 |
| Inogen, Inc. (INGN)vs › | $160.82M | 2.34 | 2.40 | 2.87 | 3.55 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 2.47 | 5.26 | 13.15 | 16.36 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | 7.90 | 9.91 | 10.86 | 18.34 |
Quick Ratio
11.22
Excludes inventory
Current Ratio
11.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.22 |
| 2026-03-31 | 19.04 |
| 2025-12-31 | 15.02 |
| 2025-09-30 | 17.82 |
| 2025-06-30 | 7.66 |
| 2025-03-31 | 8.33 |
| 2024-12-31 | 14.96 |
| 2024-09-30 | 31.84 |
| 2024-06-30 | 16.15 |
| 2024-03-31 | 40.74 |
| 2023-12-31 | 19.73 |
| 2023-09-30 | 18.26 |
| 2023-06-30 | 18.07 |
| 2023-03-31 | 16.41 |
| 2022-12-31 | 12.05 |
| 2022-09-30 | 12.80 |
| 2022-06-30 | 12.36 |
| 2022-03-31 | 15.03 |
| 2021-12-31 | 13.84 |
| 2021-09-30 | 3.72 |
| 2021-06-30 | 4.11 |
| 2021-03-31 | 3.84 |
| 2020-12-31 | 4.97 |
| 2020-09-30 | 5.98 |
| 2020-06-30 | 5.80 |
| 2020-03-31 | 1.90 |
| 2019-12-31 | 2.67 |
| 2019-09-30 | 0.01 |
| 2019-06-30 | 0.06 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.07 |
| 2018-09-30 | 0.05 |
| 2018-06-30 | 0.14 |
